In clinical trials of subjects with childhood acute ITP, adults and children with chronic ITP, and adults and children with ITP secondary to HIV, 93% of subjects had no adverse events related to WinRho^® SDF. 

WinRho® SDF Tolerability*
Most Common Adverse Events	Frequency †
Headache	2%
Chills	<2%
Fever	1%

† n=848 infusions 
*Studies were performed using WinRho/WinRho SD 

Please see Important Safety Section of this website for additional information.